BEAM
Beam Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$25.16
-0.43 ▼ -1.68%
🌙 3월 13일 7:07 PM ET (한국 3/14 08:07)
$25.17
+0.01 ▲ +0.04%
| Index | RUT | P/E | - | EPS (ttm) | -1.02 | Insider Own | 8.82% | Shs Outstand | 0.10B | Perf Week | -5.2% |
| Market Cap | 2.56B | Forward P/E | - | EPS next Y | -2.2% | Insider Trans | -1.89% | Shs Float | 0.09B | Perf Month | -3.19% |
| Enterprise Value | 1.47B | PEG | - | EPS next Q | -1.01 | Inst Own | 94.27% | Short Float | 23.57% | Perf Quarter | -8.18% |
| Income | -0.08B | P/S | 18.34 | EPS this Y | -433.6% | Inst Trans | 3.53% | Short Ratio | 11.96 | Perf Half Y | 16.75% |
| Sales | 0.14B | P/B | 2.07 | EPS next 5Y | - | ROA | -6.19% | Short Interest | 21.89M | Perf YTD | -9.24% |
| Book/sh | 12.17 | P/C | 2.06 | EPS past 3/5Y | 41.92% 28.04% | ROE | -8.11% | 52W High | -30.95% ($36.44) | Perf Year | 0.4% |
| Cash/sh | 12.23 | P/FCF | - | Sales past 3/5Y | 31.88% 466.27% | ROIC | -5.8% | 52W Low | 86.03% ($13.52) | Perf 3Y | -25.47% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 78.83% | Gross Margin | 84.05% | Volatility(W/M) | 6.34% 6.82% | Perf 5Y | -74.44% |
| Dividend TTM | - | EV/Sales | 10.53 | Sales Y/Y TTM | 120.01% | Oper. Margin | -274.57% | ATR (14) | 1.94 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 13.09 | EPS Q/Q | 313.43% | Profit Margin | -57.24% | RSI (14) | 40.85 | Recom | 1.28 |
| Dividend Gr. 3/5Y | - | Current Ratio | 13.09 | Sales Q/Q | 279.52% | SMA20 | -8.84% ($27.6) | Beta | 2.18 | Target Price | $48.13 |
| Payout | - | Debt/Eq | 0.12 | Earnings | 2000000 | SMA50 | -12.03% ($28.6) | Rel Volume | 0.91 | Prev Close | $25.59 |
| Employees | 511 | LT Debt/Eq | 0.11 | EPS/Sales Surpr. | 330.81% 877.88% | SMA200 | 7.05% ($23.5) | Avg Volume(3M) | 1.83M | Price | $25.16 |
| IPO | 2020/2/6 | Option/Short | Yes/Yes | Trades | 19029 | Volume | 1,664,475 | Change | -1.68% |
뉴스 로딩 중...